Press Release: Brian Foard appointed Head of Specialty Care Global Business Unit, member of Sanofi Executive Committee
09 Janvier 2024 - 7:30AM
Brian Foard appointed Head of Specialty Care
Global Business Unit, member of Sanofi Executive Committee
Paris, January 9, 2024. Brian
Foard, a healthcare industry veteran and Sanofi leader in the U.S.,
has been named Head of the company’s Specialty Care Global Business
Unit (GBU). With this appointment, which is effective immediately,
Brian becomes a member of Sanofi’s Executive Committee.
Brian has been interim Head of the GBU since
September 2023 while also serving as Head of Specialty Care North
America and U.S. Country Lead. Brian, who has more than 20 years of
specialty biopharma experience, has been at the helm of the
successful launch of Dupixent® in more than 50 countries across
multiple indications and age groups prior to his current role.
Paul HudsonChief Executive
Officer, Sanofi“I am very excited to have Brian join our Executive
Committee. He is clearly one of our leaders who has been actively
contributing to the success of our Play to Win strategy while
embracing our culture and values. His ability to motivate teams and
inspire success across the globe is underpinned by his
determination, strategic mindset and dedication to continue to
transform Sanofi into a world leading immunology company. Brian’s
best-in-class launch of Dupixent will help to set our roadmap for
the first- and best-in-class molecules we are preparing to launch
in the coming years.”
Brian joined Sanofi in March 2017 as the Global
Head of Dermatology and Respiratory, and held roles of increasing
responsibility, including as Head of Global Immunology for Sanofi.
He began his career with Galderma and spent more than 10 years in
the U.S. before relocating to Paris to lead global marketing and
launch readiness. During his time at Galderma, Brian also served in
roles including General Manager for Australia & New Zealand and
Vice President & General Manager of the global prescription
business unit.
Brian received a degree in business from East
Carolina University and has completed an executive education course
at Wharton. He will be based in Cambridge, Massachusetts.
Brian FoardExecutive Vice
President, Head of Specialty Care, Sanofi“I am incredibly excited
to take on this global role as Sanofi continues to drive innovation
and deliver for patients. Under Paul’s leadership and his Play to
Win strategy, Sanofi has set out on a course built for success and
Specialty Care is at the core of the company’s ambitions. With this
vision, and by doubling down on this work, we will continue to
chase the miracles of science to improve people’s lives.”
About SanofiWe are an innovative global
healthcare company, driven by one purpose: we chase the miracles of
science to improve people’s lives. Our team, across some 100
countries, is dedicated to transforming the practice of medicine by
working to turn the impossible into the possible. We provide
potentially life-changing treatment options and life-saving vaccine
protection to millions of people globally, while putting
sustainability and social responsibility at the center of our
ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ:
SNY
Media RelationsSandrine
Guendoul | + 33 6 25 09 14 25
| sandrine.guendoul@sanofi.comSally
Bain | + 1 617 834 6026
| sally.bain@sanofi.comEvan Berland | +1 215
432 0234 | evan.berland@sanofi.comNicolas
Obrist | + 33 6 77 21 27 55
| nicolas.obrist@sanofi.comVictor
Rouault | + 33 6 70 93 71 40
| victor.rouault@sanofi.com
Investor RelationsEva
Schaefer-Jansen | + 33 7 86 80 56 39
| eva.schaefer-jansen@sanofi.comArnaud
Delépine | + 33 6 73 69 36 93 |
arnaud.delepine@sanofi.comCorentine
Driancourt | + 33 6 40 56 92 21 |
corentine.driancourt@sanofi.comFelix
Lauscher | + 1 908 612 7239 |
felix.lauscher@sanofi.comTarik Elgoutni| + 1 617
710 3587 | tarik.elgoutni@sanofi.comNathalie
Pham | + 33 7 85 93 30 17 |
nathalie.pham@sanofi.com
Sanofi (EU:SAN)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Sanofi (EU:SAN)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024